Cold Atmospheric Plasma Device Extension Study

Description

Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.

Conditions

Verruca Vulgaris, Molluscum Contagiosum

Talk to us

Study Overview

On this page

Study Details

Study overview

Patients between 4-21 years of age with at least one wart or molluscum lesion are eligible to participate in this study. The duration of the study is a minimum of 4 weeks with the maximum duration of monthly treatments for one year, depending on lesion clearance. The number of lesions will be chosen by the dermatologist. Patients who opt to participate will receive non-thermal, or cold, atmospheric plasma to treat all lesions selected. Safety profile as well as changes in size, pain and appearance will be measured. Photographs and dermatologist impressions will be used to measure treatment response.

Cold Atmospheric Plasma Device for the Treatment of Molluscum Contagiosum and Verruca Vulgaris in Pediatric Patients - Open-Label Extension Study

Cold Atmospheric Plasma Device Extension Study

Condition
Verruca Vulgaris
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29425

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients from 4-21 years old with at least 1 lesion of vercurra or molluscum.
  • * Willingness of the participant and their guardian to provide consent when applicable.
  • * Unwillingness to participate in the study
  • * Received any treatment on the lesion in the past month determined by review of their medical record
  • * Immunodeficiency determined by review of their medical record.
  • * Adverse response to prior treatments determined by review of medical record.
  • * Signs of self-resolution determined by study team members.
  • * Conditions that lead to excessive scarring determined by study team members.
  • * Face and genital lesions determined by study team members.

Ages Eligible for Study

4 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medical University of South Carolina,

Study Record Dates

2025-07-01